Skip to content
Clinical Trials – home
HungaryBack to Hungary

Clinical trials in Polgar – page 21

255 clinical trials in Polgar, Hungary. Every trial is listed in the EU Clinical Trials Register and updated daily.

Polgar at a glance
255
clinical trials
  • Research sites0
Type of trial
Recruitment status
Quick filters

255 trials in Polgar

Open in trial search

Study on Ertugliflozin for Children and Teens with Type 2 Diabetes

Investigational
Countries:HungaryHungary
  • Participants:0–17 years
  • Substances:Ertugliflozin
  • Sponsor:Merck Sharp & Dohme LLC

Plasma cell myeloma

Not recruiting

Study to Compare Mezigdomide, Carfilzomib, and Dexamethasone for Patients with Relapsed or Refractory Multiple Myeloma

Registered drugNo placebo
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Carfilzomib
  • Sponsor:Celgene Corp.

Study of LY3473329 for Adults with High Lipoprotein(a) Levels at Risk for Heart Problems

Investigational
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Muvalaplin
  • Sponsor:Eli Lilly & Co.

Study on Vericiguat for Adults with Chronic Heart Failure with Reduced Ejection Fraction

Investigational
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Vericiguat
  • Sponsor:Merck Sharp & Dohme LLC

Bladder cancer

Not recruiting

Study of Pembrolizumab with Chemoradiotherapy for Patients with Muscle-Invasive Bladder Cancer

Registered drug
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Cisplatin
  • Sponsor:Merck Sharp & Dohme LLC

Study on Milvexian for Preventing Stroke in Patients with Acute Ischemic Stroke or High-Risk Transient Ischemic Attack

Registered drug
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Acetylsalicylic Acid
  • Sponsor:Janssen - Cilag International

Study of Chemotherapy With Pembrolizumab and Olaparib for Patients With Advanced Epithelial Ovarian Cancer Without BRCA Mutation

Registered drug
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Anhydrous Docetaxel
  • Sponsor:Merck Sharp & Dohme LLC

Study Comparing Darolutamide and Androgen Deprivation Therapy to Placebo and Androgen Deprivation Therapy in Men with High-Risk Prostate Cancer Recurrence

Registered drug
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Darolutamide
  • Sponsor:Bayer AG

Colitis ulcerative

Not recruiting

Study on Ustekinumab for Children with Moderate to Severe Ulcerative Colitis

Registered drug
Countries:HungaryHungary
  • Participants:0–17 years
  • Substances:Ustekinumab
  • Sponsor:Janssen - Cilag International

Renal cell carcinoma

Not recruiting

Study of Pembrolizumab and Lenvatinib for Patients with Advanced Non-Clear Cell Kidney Cancer

Registered drugNo placebo
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Lenvatinib
  • Sponsor:Merck Sharp & Dohme LLC

Crohn's disease

Not recruiting

Study on Ustekinumab for Children with Moderate to Severe Crohn's Disease

Registered drug
Countries:HungaryHungary
  • Participants:0–17 years
  • Substances:Ustekinumab
  • Sponsor:Janssen - Cilag International

Study of RO7247669 and Nab-Paclitaxel vs. Pembrolizumab and Nab-Paclitaxel for Patients with Untreated, PD-L1 Positive, Advanced Triple-Negative Breast Cancer

Registered drugNo placebo
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Sponsor:F. Hoffmann-La Roche AG

Other cities in Hungary

The busiest research cities in the country

All 73 cities in Hungary

Clinical research in Polgar

What the registry says about research in the country

01 Diabetes Research

Ongoing clinical research focusing on Type 2 Diabetes management, specifically examining treatment combinations for patients whose condition is not optimally controlled with current medications.

  • Treatment Optimization
  • Combination Therapy
  • Glycemic Control

The trials aim to evaluate the effectiveness of combining different diabetes medications to improve blood sugar control in patients who haven't achieved optimal results with dapagliflozin treatment alone or in combination with metformin.

02 Metabolic Disorders

Research initiatives exploring innovative approaches to managing metabolic disorders, with a primary focus on glycemic control optimization in diabetes care.

  • Blood Sugar Management
  • Treatment Efficacy
  • Safety Assessment

These studies evaluate new therapeutic combinations to enhance treatment outcomes for patients with inadequately controlled diabetes, measuring both effectiveness and safety parameters.

03 Therapeutic Combinations

Investigation of combination therapies in diabetes management, specifically studying the synergistic effects of different diabetes medications.

  • Drug Interactions
  • Treatment Response
  • Patient Outcomes

The research focuses on determining superior treatment combinations for better glycemic control in patients who haven't achieved optimal results with current therapeutic approaches.

Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.